Agar-based films are promising biodegradable materials, but their brittleness and moisture sensitivity limit practical use. In this study, a phytochemical extract from the Australian halophyte pigface ( Carpobrotus glaucescens ) was evaluated as a concentration-dependent modifier of agar films. CHNS, FTIR, ¹H NMR and untargeted LC-MS established a chemically complex, hydroxyl-rich composition; these analyses provide a baseline compositional context but do not directly demonstrate a specific agar-extract bonding mechanism. Across the formulation-screening matrix, P6 (agar-to-extract ratio, A:PF = 1:20, w/v) showed a 38% increase in tensile strength and an elongation at break of approximately 23% relative to the control, while water vapour permeability decreased from 2.91 × 10⁻¹¹ to 1.26 × 10⁻¹¹ g/m²·s·Pa ( p < 0.05). These property changes coincided with qualitative changes in film FTIR profiles, surface morphology, apparent glass-transition behaviour and drying kinetics; however, the independent contributions of agar and extract could not be isolated because both concentrations varied in the screening design. At higher extract loading, P9 (A: PF = 1:40, w/v) showed particulate surface heterogeneity and lower mechanical performance. Antioxidant activity was retained, with total phenolic content reaching 28.0 mg GAE/g. The selected intermediate films remained hydrophilic, and all formulations were highly water-soluble. The results identify a favourable intermediate formulation window for exploratory short-term, low-moisture or non-food biodegradable applications. Food-contact or edible use would require improved water resistance, arsenic speciation, migration testing and toxicological assessment.
No takes yet. Share an insight, caveat, or question.
Naik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: